Explore more publications!

Latin America News Hub: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Latin America News Hub.

Press releases published on January 5, 2026

MedicareVideoGuide.com Reports Significant Medigap Rate Increases and Expands Support Services for Seniors
Encore Oilfield Services, LLC Announces Acquisition of Custom Compression Systems
Lloydshare Loyalty Participated in LASOS 2025 Summit in Punta Cana
Neuro Force One Welcomes Danny Hester as Brand Ambassador to Drive Innovation in Training and Recovery
C&M invertirá fuertemente en México en 2026 con soluciones integradas de comunicación e IA
Houston's Baker energy consultancy announces a workshop by its artist-in-residence Mary Baker
Hilliard Law Announces Promotion of Alex Hilliard and Bonnie J. Rickert to Partner
Trident Resources Engages New Era Publishing Inc. for Corporate Marketing and Investor Awareness Services
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock
Free LearningMole Platform Launches Over 500 Free Spanish-Language Educational Videos for Children
REEZ.io Expands Cryptocurrency Payment Options with Addition of 50+ Crypto Assets
Processa Pharmaceuticals Completes Enrollment of 20th Patient for Formal Interim Analysis in Phase 2 NGC-Cap Breast Cancer Study
ALPHAMIN ANNOUNCES RESIGNATION OF DIRECTOR
Nxera Pharma to Present at the 44th Annual J.P. Morgan Healthcare Conference
Appointment of Fiona Sharp to the Board as Chief Financial Officer and Company Secretary
Corvus Pharmaceuticals Confirms Plans to Announce Results from Cohort 4 of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis in January 2026 Following Annual Healthcare Conference
Brookfield Renewable to Host Fourth Quarter 2025 Results Conference Call
Kyverna Therapeutics to Present at the J.P. Morgan 2026 Healthcare Conference
Crinetics Announces Strong PALSONIFY Launch Execution and Positive Results for Concurrent Androstenedione Lowering and Glucocorticoid Dose Reduction in Phase 2 Trial of Atumelnant for Congenital Adrenal Hyperplasia

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions